搜索临床试验以:Dasatinib Placebo
总计55034个结果
-
University of California, DavisBristol-Myers Squibb; National Cancer Institute (NCI); Genentech, Inc.终止
-
Cancer Institute and Hospital, Chinese Academy...招聘中
-
The First Affiliated Hospital with Nanjing Medical...Jiangsu HengRui Medicine Co., Ltd.; Beijing gene plus technology co., LTD完全的
-
Shanghai Ninth People's Hospital Affiliated to...未知
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityJiangsu Hengrui Pharmaceutical Co., Ltd.招聘中
-
Sun Yat-sen University主动,不招人
-
Peking University Cancer Hospital & InstitutePeking University First Hospital; Shanxi Province Cancer Hospital; Peking University Third Hospital 和其他合作者完全的
-
Peking Union Medical College HospitalJiangsu HengRui Medicine Co., Ltd.完全的
-
Henan Cancer Hospital未知
-
University College, LondonBoehringer Ingelheim完全的
-
Tianjin Medical University Cancer Institute and...Zhejiang Cancer Hospital; Fudan University; Liaoning Tumor Hospital & Institute; Gansu Cancer Hospital未知
-
Boehringer Ingelheim完全的
-
Boehringer Ingelheim终止
-
Amsterdam UMC, location VUmc完全的
-
National Cancer Institute (NCI)完全的原发隐匿的转移性鳞状颈癌 | 原发性隐匿的复发性转移性鳞状颈癌 | 下咽部复发性鳞状细胞癌 | 喉部复发性鳞状细胞癌 | 唇和口腔的复发性鳞状细胞癌 | 复发性口咽鳞状细胞癌 | 鼻窦和鼻腔的复发性鳞状细胞癌 | 唾液腺鳞状细胞癌 | 复发性鼻咽鳞状细胞癌 | 下咽部 IV 期鳞状细胞癌 | IV 期喉鳞状细胞癌 | 唇和口腔的 IV 期鳞状细胞癌 | IV 期鼻咽鳞状细胞癌 | IV 期口咽鳞状细胞癌 | 原发隐匿的未经治疗的转移性鳞状颈癌 | 副鼻窦和鼻腔的 IV 期鳞状细胞癌美国
-
West China HospitalJiangsu HengRui Medicine Co., Ltd.未知
-
Bristol-Myers SquibbPPD; European Organisation for Research and Treatment of Cancer - EORTC; ICON plc; Molecular MD; M... 和其他合作者完全的
-
Versailles Hospital完全的白血病,淋巴细胞,急性法国, 意大利, 比利时, 德国
-
Sun Yat-sen University招聘中
-
National Health Research Institutes, TaiwanChina Medical University Hospital; Chang Gung Memorial Hospital; Kaohsiung Medical University... 和其他合作者邀请报名
-
Guilin Medical University, ChinaWuzhou Red Cross Hospital; Guangxi Naxishan Hospital; National Hospital of Guangxi Zhuang Autonomous...未知
-
Tongji University未知
-
Massachusetts General HospitalBristol-Myers Squibb; TargetCancer Foundation完全的
-
H. Lee Moffitt Cancer Center and Research InstituteBristol-Myers Squibb终止
-
Latin American Cooperative Oncology GroupGlaxoSmithKline完全的管理系统1 | 开始研究的绩效状态为零到二 | 接受最多一次化疗的患者 | 紫杉烷类药物后进展的患者阿根廷, 巴西, 秘鲁